When you apply sunscreen all over your body as recommended, your body absorbs some of the chemicals in it so much that they show up in your blood within a day — more than what the FDA considers a safety concern level.
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
This claim is based on controlled human pharmacokinetic studies (e.g., FDA 2019 study in JAMA) that measured plasma concentrations of sunscreen ingredients after standardized maximal use. The 0.5 ng/mL threshold is an FDA regulatory benchmark for systemic exposure, and the study design directly measured plasma levels over time. The claim uses precise quantitative language ('exceeding 0.5 ng/mL within 24 hours') and is supported by empirical data. No overstatement is present because the claim is limited to absorption magnitude and timing, not health effects.
More Accurate Statement
“After a single application of sunscreen under maximal use conditions, systemic absorption of active ingredients occurs rapidly, resulting in plasma concentrations that exceed the FDA’s threshold of 0.5 ng/mL within 24 hours.”
Context Details
Domain
medicine
Population
human
Subject
Systemic absorption of sunscreen active ingredients
Action
occurs rapidly, with plasma concentrations exceeding
Target
the FDA’s 0.5 ng/mL threshold within 24 hours after a single application under maximal use conditions
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial.